| Tag | Content |
|---|
EnhancerAtlas ID | HS082-20495 |
Organism | Homo sapiens |
Tissue/cell | HCASMC |
Coordinate | chr2:225773990-225775780 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Atoh1 | MA0461.2 | chr2:225775293-225775303 | AACATATGTT | + | 6.02 | | Atoh1 | MA0461.2 | chr2:225775293-225775303 | AACATATGTT | - | 6.02 | | JUN | MA0488.1 | chr2:225774655-225774668 | AATATGATGTCAT | + | 6.41 | | ZBTB18 | MA0698.1 | chr2:225775177-225775190 | TGTCCAGATGTTG | + | 6.05 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_09679 | chr2:225773393-225776784 | CD14 | | SE_11129 | chr2:225773422-225776848 | CD20 | | SE_18264 | chr2:225773607-225775793 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19524 | chr2:225774075-225775559 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20427 | chr2:225774064-225775819 | CD56 | | SE_45675 | chr2:225773185-225776863 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 225774741 | 225775150 | | chr2 | 225774579 | 225775611 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I224908 | chr2 | 225773581 | 225776316 |
|
Enhancer Sequence | TATCACGGAA GTGTTTAGAT ATTTTTTATG GTTATGGATG TTCATTTTAA GCCACTTAAG 60
CAGATTCAGA TAAAGACAAT GCTCTCCAGT AGTTGTTTTC CAAGTGTTTT CATACTATTG 120
CTATATTTAT TTTCAGAATC ACAGCATTAG GATTTTTCAT ATCCCTATTT AAAGATGGAA 180
AAACTAAGGC AGAAAAGTTA ATAGTTTGCC AAAATGAAGG ATACGTTCCC TTGTGAGGAG 240
TGGAAGTACC CTCATCCAGT CAGGCTAGTG AGCATGTGGT ATAAAGGAAC TTATCAAAGG 300
ATCAGAGACA ATAAAATGTG TAAGAACATG GAATATTATG TCAAAGATAG CAAAGCCTTA 360
ATTCTGGCTC TGTGTGAACT TGGGCGAGTT CATTATTCAC TCAGAGCCTG TTTTCTAGGC 420
TGCAAAATGA GGTAGTAATA CCTATTTCAC AGAGTTCTCA AAAGTTTTCA CATACACACA 480
ATGTATAAGC AACTGTGTAC TCAACTAGAG CTTGATGTTA ACATGCAGTG TTTTAATGGA 540
TGTGAAATAA GCCTATGCTT TTGTGTGGGG AATGTTTAAT TTTACATTTA AGAGATAGGG 600
AGGAGAATTA ATAACAGATA AAACAGAAAA GGAAGAAGCT GTTCATTTTA GTGAACTTCC 660
ATTAAAATAT GATGTCATTG AAGATTAAAA AAAAGAAAAG AATGCCTAAT GCCTTTCATG 720
AGAAGCTGAG AATTGTCAAA GTAGAGAGCA GTGAGAGAAA ACTCAAATTT TTTACTGAGC 780
TGGATGTGTT GAAACTAGAT TCTTGCCAAT CTGTTGCCTA GCAACCATGG TATTTGCCCT 840
TGCCACCCCA CAGTGAGCCG CAGGGCAATG TAGCACAGGG TGGACCAATA ACGTTGCTTA 900
ATACACTTGT GGTAGGTCAA GCAAGTGTTT CTACAAAGCT CTACAAACGT CAATGAATTC 960
ATTTCAGTGC TAGCATAATC TAGTTTCAAA AATCCAGCCA ATGTTCCTGA AAGTGTGGCC 1020
CACTGACTGT ATGCATCAGA GTCACCTGAG CAGAAACCAC AGTGGGGCTG TGAGGGTGAA 1080
GACTCAGAGA AGTTTTCTTT CCAGAGGAAC ATAGCAATTT TATAGCAAAA CACCCTATTG 1140
GCAGTTAGCA TCGCAGTTAG GAGCCCAGGG ACGGAGCTGG TGGCATGTGT CCAGATGTTG 1200
GATCTGTCTA TTCCTGGTTG TCTAATGCTG GCTGGGCAAG TTTCTTAATA TTTCTATGAC 1260
ATAGTTTCCT TGTTATTAAA AGGTGATAAT GATGATAATA ACAAACATAT GTTTGTAATT 1320
GCTACAAGTA AAGGGCTTAG AAGTGTATCT GGCACAAAGT AAGCAGTCAA TAAAGGTTAG 1380
CTGCTATTAG CAATTGGGGT CAAGACTTTT TGCAGTGTAA TTCTCTGGGA CCATTTCCCA 1440
GTCTTAGCTC AGCTCTTTGG TGACCTCTTT CTTCTTATCT GCTGTCTCCA GGCCTGACTA 1500
TTCATGTTCC ATTATCATCA CGGGATATTT GTAAGCAGGG CTTATCTTCT TCCCATCCTA 1560
TGAAGCACAG GTTTCACTTT ATCTTTATCC TTAAAATCAA GGACTACTAT GGGAGTTTTT 1620
GCAGGGTTTT CAGTACTAGT GACACAGAAA AATTAGCAGG GAATAAGGTA GTTTTGTCCC 1680
AGTCTTCCTC CTTTCTCTCT CCCTTTTTTT TTTCTATTTT AGATCCATAC AGTTGAGAAA 1740
AAATATGATA AGAAGATTCA TTCATGTTGC CCAAGAGAGT TGAATGTTCT 1790
|
